相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future
Eric S Christenson et al.
LANCET ONCOLOGY (2020)
Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer
Xinyi Wang et al.
MOLECULAR ONCOLOGY (2020)
Neoadjuvant Treatment for Patients With Localized Pancreatic Adenocarcinoma Are We There Yet?
Wilson Luiz da Costa Jr et al.
JAMA ONCOLOGY (2020)
Pancreatic cancer stroma: an update on therapeutic targeting strategies
Abdel N. Hosein et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
被撤回的出版物: Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma (Retracted article. See vol. 533, 2022)
Chenyu Ding et al.
CANCER LETTERS (2020)
Extracellular Vesicles in Diagnosis and Treatment of Pancreatic Cancer: Current State and Future Perspectives
J. Spencer Lane et al.
CANCERS (2020)
Top ten research priorities for pancreatic cancer therapy
Rosa Klotz et al.
LANCET ONCOLOGY (2020)
Chemotherapy and Tumor Evolution Shape Pancreatic Cancer Recurrence after Resection
Filip Bednar et al.
Cancer Discovery (2020)
Down-Regulation of SIRT1 Expression by mir-23b Contributes to Lipid Accumulation in HepG2 Cells
Mohammad Borji et al.
BIOCHEMICAL GENETICS (2019)
Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer
Christopher J. Halbrook et al.
CELL METABOLISM (2019)
Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin
Caijun Dong et al.
ONCOTARGETS AND THERAPY (2019)
Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer A Phase 2 Randomized Clinical Trial
Thomas B. Karasic et al.
JAMA ONCOLOGY (2019)
miR-23b-3p regulates apoptosis and autophagy via suppressing SIRT1 in lens epithelial cells
Wenkai Zhou et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Xinming Jing et al.
MOLECULAR CANCER (2019)
The Roles of Hypoxia-Inducible Factors and Non-Coding RNAs in Gastrointestinal Cancer
Hyun-Soo Cho et al.
GENES (2019)
LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α
Zhu Zeng et al.
THERANOSTICS (2019)
Circular RNAs are abundantly expressed and upregulated during human epidermal stem cell differentiation
Lasse Sommer Kristensen et al.
RNA BIOLOGY (2018)
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Philippe Icard et al.
DRUG RESISTANCE UPDATES (2018)
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer
Surendra K. Shukla et al.
CANCER CELL (2017)
SIRT1 deacetylates and stabilizes hypoxia-inducible factor-1α (HIF-1α) via direct interactions during hypoxia
Hyun-Yoo Joo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1
Helena Doktorova et al.
BIOMEDICAL PAPERS-OLOMOUC (2015)
Identification and Characterization of Hypoxia-Regulated Endothelial Circular RNA
Jes-Niels Boeckel et al.
CIRCULATION RESEARCH (2015)
SIRT1 inhibition in pancreatic cancer models: Contrasting effects in vitro and in vivo
Chern Ein Oon et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2
Y. An et al.
CELL DEATH & DISEASE (2015)
The role of P-glycoprotein in drug resistance in multiple myeloma
Joseph Abraham et al.
LEUKEMIA & LYMPHOMA (2015)
Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy-induced stress
Jun-gang Zhang et al.
CANCER SCIENCE (2014)
HIF-1 Signaling in Drug Resistance to Chemotherapy
N. A. Warfel et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer
Kenji Takahashi et al.
FEBS OPEN BIO (2014)
MicroRNA 23b Regulates Autophagy Associated With Radioresistance of Pancreatic Cancer Cells
Peng Wang et al.
GASTROENTEROLOGY (2013)
Therapeutic Advances in Pancreatic Cancer
Andrew Scott Paulson et al.
GASTROENTEROLOGY (2013)
MS2-TRAP (MS2-tagged RNA affinity purification): Tagging RNA to identify associated miRNAs
Je-Hyun Yoon et al.
METHODS (2012)
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
Nadine Rohwer et al.
DRUG RESISTANCE UPDATES (2011)
Suppression of dual-specificity phosphatase-2 by hypoxia increases chemoresistance and malignancy in human cancer cells
Shih-Chieh Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
HIF-1: upstream and downstream of cancer metabolism
Gregg L. Semenza
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Rab27a and Rab27b control different steps of the exosome secretion pathway
Matias Ostrowski et al.
NATURE CELL BIOLOGY (2010)
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Huafeng Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ceramide triggers budding of exosome vesicles into multivesicular Endosomes
Katarina Trajkovic et al.
SCIENCE (2008)
Hypoxia-inducible factor-1α and the glycolytic phenotype in tumors
IF Robey et al.
NEOPLASIA (2005)
Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine
K Yokoi et al.
CLINICAL CANCER RESEARCH (2004)
YGI: A potential anticancer drug targeting hypoxia-inducible factor 1
EJ Yeo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
分享论文
